BluePointe Capital Management’s Johnson & Johnson JNJ Stock Holding History

BluePointe Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$431K	Buy	+2,601	New	+$407K	0.16%	82

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BluePointe Capital Management's JNJ Position: Q1 2025 in Review

BluePointe Capital Management opened a new position in Johnson & Johnson (JNJ) in Q1 2025: 2,601 shares worth $431K. The stake represents 0.16% of the portfolio and ranks #82 among its holdings.

4,157 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

BluePointe Capital Management held 2,601 shares of Johnson & Johnson worth $431K as of Q1 2025.
Johnson & Johnson was a new BluePointe Capital Management position in Q1 2025.
Johnson & Johnson made up 0.16% of BluePointe Capital Management's portfolio in Q1 2025, its #82 holding.
4,157 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on BluePointe Capital Management's 13F filing for Q1 2025, filed 2 May 2025.